[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-32. [2] 叶剑飞. microRNAs与肿瘤研究的新进展[J]. 天津医科大学学报, 2014, 20(5): 416-418. [3] Huang T, Wang G, Yang L, et al. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1[J]. Cancer Biomark, 2017, 21(1): 221-228. [4] Zhao L, Liu L, Dong Z, et al. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis[J]. Oncol Rep, 2017, 38(6): 3522-3530. [5] Xu J, Wu W, Wang J, et al. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7[J]. Oncol Rep, 2017, 37(2): 1052-1058. [6] Shi C, Xu X.MiR-670-5p induces cell proliferation in hepatocellular carcinoma by targeting PROX1[J]. Biomed Pharmacother, 2016, 77: 20-26. [7] Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?[J]. World J Clin Oncol, 2014, 5(2): 71-81. [8] 杨尊敬, 杜先玲. 细胞周期蛋白依赖性激酶在miR-193a5p调控卵巢癌细胞增殖及上皮细胞间充质转变中的作用[J]. 中国应用生理学杂志, 2020, 36(2): 176-180. [9] Nolte E,Wach S, Silva IT, et al. A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines[J]. Oncotarget, 2017, 8(7): 11676-11691. [10] Song H, Xu D, Shi P, et al. Upregulated circ RNA hsa_circ_0000337 promotes cell proliferation, migration, and invasion of esophageal squamous cell carcinoma[J]. Cancer Manag Res, 2019, 11: 1997-2006. [11] 周喆焱, 阮 锐, 边 莉. E-cadherin对非小细胞肺癌的转移和靶向治疗的影响[J]. 昆明医科大学学报, 2014, 35(4): 164-167. [12] 史鹏飞, 吉海龙, 罗永康, 等. 长链非编码RNA SPRY4-IT1对髓母细胞瘤增殖及侵袭转移的影响[J]. 中国应用生理学杂志, 2017, 33(1): 78-82. [13] Zhang L, Li N, Yan HC, et al. Expression of novel CD44st and MMP2 in NSCLC tissues and their clinical significance[J]. Oncol Res Treat, 2017, 40(4): 192-196. [14] Li J, Liu J, Ren Y, et al. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer[J]. Exp Biol Med, 2015, 240(3): 324-328. [15] Wang M, Li Y, Wu M, et al. WWOX suppresses cell growth and induces cell apoptosis via inhibition of P38 nuclear translocation in cholangiocarcinoma[J]. Cell Physiol Biochem, 2014, 34(5): 1711-1722. [16] Zheng QW, Zhou YL, You QJ, et al. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2[J]. Cancer Gene Ther, 2016, 23(12): 433-438. [17] Wang XH, Gan CZ, Xie JY. Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo[J]. Thorac Cancer, 2018, 9(12): 1583-1593. |